Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

VENUS REMEDIES LTD. - 526953 - Board Meeting Intimation for Meeting Of Board Of Directors Is Scheduled To Be Held On 31St January, 2022.

 VENUS REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2022 ,inter alia, to consider and approve Meeting of Board of Directors is scheduled to be held on 31st January, 2022 inter alia consider and approve Unaudited Financial Results for the quarter ended on 31st December 2021 and any other business with the permission of Chair.
20-01-2022
Bigul

VENUS REMEDIES LTD. - 526953 - Statement Of Investor Complaints For The Quarter Ended December 2021

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 033330 Name of the Signatory :- NehaDesignation :- Company Secretary and Compliance Officer
07-01-2022
Bigul

VENUS REMEDIES LTD. - 526953 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 In compliance with Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants)Regulation, 2018, we enclose herewith Confirmation Certificate received from our Registrar & Transfer Agent, M/s. Link Intime India Pvt Ltd. for the quarter ended 31.12.2021
07-01-2022
Bigul

VENUS REMEDIES LTD. - 526953 - Shareholding for the Period Ended December 31, 2021

 Venus Remedies Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here
07-01-2022
Bigul

VENUS REMEDIES LTD. - 526953 - Closure of Trading Window

 Pursuant to the Code of Conduct adopted by the Company under SEBI (Prohibition of Insider Trading) Regulations, 2015, this is to inform that the trading window for dealing in equity shares of the Company shall remain closed for all Designated Persons of the Company, as defined under the said Regulations, from January 1, 2022 till 48 hours from the declaration of the Unaudited Financial Results for the Quarter ending December 31, 2021.
01-01-2022
Bigul

VENUS REMEDIES LTD. - 526953 - Announcement under Regulation 30 (LODR)-Change in Directorate

 Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), we wish to inform you that based on the recommendation of Nomination and Remuneration Committee, the Board of Directors have appointed Dr. Savita Gupta as Additional Director (Non- Executive Independent Director) w.e.f. 30th December 2021 to hold office till the conclusion of the next General Meeting and will be appointed as regular Non -Executive Independent Director for five consecutive years, subject to approval of members in the next general meeting.
30-12-2021
Bigul

VENUS REMEDIES LTD. - 526953 - Board Meeting Outcome for Outcome Of Board Meeting

 This has reference to the meeting of Board of Directors held on 30th December 2021 inter alia considered and approved the appointment of Dr. Savita Gupta as Additional Director (Non- Executive Independent Director) w.e.f. 30th December 2021 to hold office till the conclusion of the next General Meeting and will be appointed as regular Independent Non -Executive Director for five consecutive years, subject to approval of members in the next General Meeting.
30-12-2021
Bigul

VENUS REMEDIES LTD. - 526953 - Board Meeting Intimation for Board Meeting Scheduled To Be Held On 30.12.2021.

 VENUS REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/12/2021 ,inter alia, to consider and approve Board meeting scheduled to be held on 30.12.2021 to consider the appointment of additional director- Independent director.
23-12-2021

Pharma firm Venus Remedies makes the cut for PLI Scheme

 Under this scheme, Venus Remedies will make a committed investment in plant and machinery, get incentives on incremental sales of pharmaceutical products
10-12-2021
Bigul

VENUS REMEDIES LTD. - 526953 - Venus Remedies Limited has been selected for Production Linked Incentive Scheme (PLI) of the Government of India

 Venus Remedies Ltd has informed BSE regarding "Venus Remedies Limited has been selected for Production Linked Incentive Scheme (PLI) of the Government of India."
08-12-2021
Next Page
Close

Let's Open Free Demat Account